Physician

Shantilal S Patel, M.D.

According to 2025 Medicare claims, Shantilal Patel, M.D. (NPI: 1578672622) practices cardiology in the Terre Haute, IN market, with the plurality of this provider's patient population coming from Vigo, IN. This provider's primary affiliated billing organization is UNION ASSOCIATED PHYSICIANS CLINIC, LLC (NPI: 1891028379; TIN: 27-0581401) and primary practice location at 47807-1037. Patel is affiliated with the IRCCO (ACO ID: A2619), Central Florida ACO (ACO ID: A2801), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,801 traditional Medicare patients, billed 8,304 HCPCS/CPT codes, and received $343,753 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,282 prescription claims across 1,474 beneficiaries totaling $1,775,625 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 24 claims. Open Payments data shows 32 records totaling $1,013. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $1,047,540 to $343,753. In contrast, Part D prescription costs have moved sharply higher in recent years, from $719,939 to $1,775,625. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $59,687 and ending at $21,736.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,858	19,757	$1,047,540
2016	2,674	17,420	$961,180
2017	2,537	14,242	$741,881
2018	2,554	13,189	$579,710
2019	2,268	12,500	$524,348
2020	1,929	9,478	$416,197
2021	1,911	8,908	$434,209
2022	1,743	6,710	$357,820
2023	1,714	6,745	$339,887
2024	1,801	8,304	$343,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,191	16,836	$719,939
2016	1,284	16,767	$826,643
2017	1,241	15,367	$833,460
2018	1,297	14,510	$928,494
2019	1,312	13,478	$1,010,809
2020	1,236	12,404	$1,081,040
2021	1,263	11,981	$1,255,201
2022	1,225	11,168	$1,507,253
2023	1,321	11,092	$1,658,153
2024	1,474	12,282	$1,775,625

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	81	$59,687
2016	18	94	$95,746
2017	N/R	25	$52,201
2018	23	50	$107,105
2019	N/R	21	$45,464
2020	N/R	26	$56,862
2021	N/R	44	$45,660
2022	N/R	24	$1,492
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	652	865	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	472	556	$59
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	569	578	$49
93880	Ultrasound of both sides of head and neck blood flow	207	210	$27
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	504	726	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	590	32,848	$629,353
Xarelto	Rivaroxaban	385	21,710	$402,000
Entresto	Sacubitril/Valsartan	191	11,591	$237,451
Jardiance	Empagliflozin	136	8,969	$167,313
Repatha Sureclick	Evolocumab	57	4,165	$78,328

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$1,013	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shantilal S. Patel, M.D.?

Tedicare shows public-source Medicare data for Shantilal S. Patel, M.D. (NPI 1578672622), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shantilal S. Patel, M.D. have ACO affiliation data?

Shantilal S. Patel, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Central Florida ACO (MSSP, ACO ID A2801), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Shantilal S. Patel, M.D.?

Shantilal S. Patel, M.D. is linked to UNION ASSOCIATED PHYSICIANS CLINIC, LLC (billing NPI 1891028379) in the available physician profile data.

Does Shantilal S. Patel, M.D. have Open Payments data?

Shantilal S. Patel, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.